Prognostic impact of RPL15 overexpression in intrahepatic cholangiocarcinoma: a marker of aggressive tumor behavior
Overexpression of RPL15 was identified as an adverse prognostic factor predicting worse outcomes in intrahepatic cholangiocarcinoma. RPL15 could serve as a potential therapeutic target to aid in developing new treatment strategies.
Authors
- Ti‐Chun Chan
- Chung‐Hsi Hsing (ORCID: https://orcid.org/0000-0002-6091-5371)
- Chia‐Ling Chou
- Wen‐Ching Wang (ORCID: https://orcid.org/0000-0002-7422-3667)
- Yu-Hsuan Kuo
- Chien‐Jui Huang (ORCID: https://orcid.org/0000-0002-5503-9266)
- Khaa Hoo Ong
- Hong-Lin He
- Wan‐Shan Li (ORCID: https://orcid.org/0000-0003-4386-0572)
- Yu-Feng Tian (ORCID: https://orcid.org/0000-0002-5607-7088)
- Ding‐Ping Sun
- Han-Ping Hsu
Institutions
- Chung Hwa University of Medical Technology (TW)
- National Sun Yat-sen University (TW)
- National Health Research Institutes (TW)
- Chi Mei Medical Center (TW)
- National Cheng Kung University Hospital (TW)
- Chia Nan University of Pharmacy and Science (TW)
- I-Shou University (TW)
Publication Details
- Journal
- Diagnostic Pathology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1186/s13000-025-01699-y
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chi Mei Medical Center